je.st
news
Tag: cancer
New KEYTRUDA (pembrolizumab) Data at 2016 ASCO Annual Meeting Includes Three-Year Overall Survival Data in Melanoma and Updated Overall Survival Data in Non-Small Cell Lung Cancer As Well As Updated Findings in Head and Neck Cancer
2016-05-16 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Data at ASCO Evaluates KEYTRUDA As Single Agent and in Novel Combinations in More Than 15 Different Cancers, Including Several New Tumors KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that new and updated data investigating KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in more than 15 types of cancer will be presented at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 3 7, 2016. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558Kim Hamilton, (908) 740-1863orInvestor:Teri Loxam, (908) 740-1986Justin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
EPA Determines Glyphosate Likely Does Not Cause Cancer
2016-05-10 07:02:00| Chemical Processing
Review panel makes assessment regarding the pesticide after analyzing dozens of scientific studies.
Tags: not
cancer
determines
epa
Hormel Launches Foods for Cancer Patients
2016-05-09 17:17:00| Food Processing
Hormel's new Vital Cuisine line includes ready to eat meals, nutrition shakes, and protein powders specially designed to serve the needs of cancer patients.
Tags: cancer
patients
foods
launches
Woman awarded $55m in talc cancer case
2016-05-03 11:23:38| BBC News | Business | UK Edition
A US jury court orders Johnson & Johnson to pay $55m (40m) to a woman who woman who says its talcum powder caused her ovarian cancer.
Tags: case
woman
cancer
awarded
Partners HealthCare Announces The 2016 Disruptive Dozen' Technologies That Can Revolutionize Cancer Care
2016-05-03 03:10:11| drugdiscoveryonline News Articles
Partners HealthCare recently announced its selections for the second annual “Disruptive Dozen,” the 12 emerging technologies with the potential to revolutionize cancer care over the next decade
Tags: care
partners
technologies
cancer
Sites : [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] next »